Skip to main content
. 2012 Oct 10;6:1651–1664. doi: 10.2147/OPTH.S29909

Table 7.

The number of the patients receiving topical antiglaucoma drugs at 24 months postoperatively in each group

Postoperative antiglaucoma treatment Group A (N = 25) Group B (N = 24) Group C (N = 22)
Complete failure 4 (16%) 2 (8.3%) 4 (18.8%)
No treatment 14 (56%) 15 (62.5%) 9 (40.9%)
1 drug 1 (4%) 2 (8.3%) 0
2 drugs 6 (24%) 5 (20.8%) 6 (27.2%)
3 drugs 0 0 3 (13.6%)